Data supplements
Online appendices
- Appendix 1: Benefits of screening to prevent fragility fractures
- Appendix 10: GRADE Evidence to Decision Framework
- Appendix 11: Task Force Public Advisors Network (TFPAN) Protocol
- Appendix 2: Benefits of pharmacologic treatments
- Appendix 3: Calculations for overdiagnosis
- Appendix 4: Harms (pharmacological) of screening to prevent fragility fractures
- Appendix 5: Accuracy of risk assessment tools (calibrated for Canada)
- Appendix 6: Patient preferences for screening to prevent fragility factures: Data summary
- Appendix 7: Fragility Fractures Community Jury: Data Summary Report
- Appendix 8: Cost-effectiveness Analyses of 2-step Screening via SCOOP RCT
- Appendix 9: Analytical Framework
Earn CPD Credits
This article is eligible for 0.5 Mainpro+ credits.
Did you read this article?
Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.
Podcast
Podcast